About us
Find out everything about the team, sponsors and our network
The DECODE VRL study is led by an interdisciplinary team of leading experts from ophthalmology, pathology, oncology and molecular biology. Our work is supported by Deutsche Krebshilfe and is based on cutting-edge science, collaboration and tireless efforts to improve patient care.
Deutsche Krebshilfe (German Cancer Aid) plays a decisive role in funding the DECODE VRL study. It has been working for years to improve diagnosis and treatment options for cancer and provides the financial resources to achieve the ambitious goals of this study.
The support from Deutsche Krebshilfe highlights the social relevance of the DECODE VRL study and its potential to fundamentally transform cancer diagnostics.
Department of Ophthalmology, University Hospital Schleswig-Holstein (UKSH), Lübeck Campus/ Chief Physician Chemnitz Clinic
Head of Department, Department of Pathology, Tübingen University Hospital
Head of Molecular Pathology Diagnostics, Tübingen University Hospital Expert in Hematopathology & Molecular Lymphoma Diagnostics
biologist, scientist, laboratory manager
Research assistant, study management, regulatory compliance, quality control and interdisciplinary team leadership.
Digital Media and Artificial Intelligence Expert, Leadership Coach, Institute for Collective Dialogue
Professor Dr. Peter Martus
Institute of Medical Biometry and Statistics, University of Tübingen
Responsible for biometric planning and statistical evaluation of study results.
Professor Gerald Illerhaus
German Lymphoma Alliance and Stuttgart Hospital
Expert in the diagnosis and treatment of primary CNS lymphoma
Professor Dr. Andreas Stahl
Greifswald University Medical Center and chairman of retina.net
Management of the network of participating eye clinics and coordination of registry entries.
Whether as a patient, relative, medical professional colleague or supporter: Your involvement and interest are decisive for the success of the DECODE VRL study.
Contact us if you have any questions about the study, participation or the scientific background.
Liv Dollmann
Study coordination
Department of Ophthalmology, University Hospital Schleswig-Holstein
Lübeck Campus
Phone: +49 451 500-43911
email: liv.dollmann@uksh.de
Working together for better diagnosis and treatment of vitreoretinal lymphoma.
“Your support brings us one step closer to deciphering lymphoma in the eye”
